That is what seperates DPDW from 99.9% of the OTC market. For all who dont know - DPDW is currently being followed by 2 institutions (Trophy Brothers and Dalhamn Rose) and Dalhman Rose has put out its estimates for 2008 numbers and has a $2.50 price target.
Here is the yahoo link for the Dalhman Rose 2008 numbers excluding MAKO (our newest acquisition who did $6.8M in revenues in 2006.)
Not sure how you took all of that from my last post Brikk. I was simply saying I appreciate Techisbest's candor. Something about the way I speak my mind obviously bothers you. While I won't change my interest in critical analysis, I have become disinterested in defending my character. If you have problems with specific numbers, address it directly. Otherwise, perhaps it's best if you just put me back on ignore.